Edit Siket-Szasz

Title: Edit Siket-Szasz: Innovator in Radiation Treatment Technology

Introduction

Edit Siket-Szasz is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of radiation treatment technology, holding 2 patents that enhance the precision and effectiveness of treatment plans. Her innovative approaches have the potential to improve patient outcomes in medical settings.

Latest Patents

One of her latest patents is titled "Interactive dose manipulation using prioritized constraints." This method involves the interactive manipulation of the dose distribution of a radiation treatment plan. After obtaining an initial candidate treatment plan, a set of clinical goals is transformed into constraints. Each constraint is expressed in terms of a threshold value for a respective quality index of the dose distribution. The dose distribution can be modified interactively by adjusting the threshold values for these constraints. Re-optimization can be performed based on the modified threshold values, allowing users to assign relative priorities among the constraints. When a constraint is modified, the re-optimized treatment plan may not violate those constraints with higher priorities than the modified constraint, while it may violate those with lower priorities.

Career Highlights

Edit has worked with notable companies in the medical technology sector, including Varian Medical Systems International AG and Siemens Healthineers International AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in radiation treatment.

Collaborations

Edit has collaborated with esteemed colleagues such as Esa Kuusela and Marco Lessard. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Edit Siket-Szasz is a trailblazer in the field of radiation treatment technology, with her patents reflecting her commitment to improving patient care. Her work continues to influence the medical community and drive innovation in treatment methodologies.